Efficacy of venlafaxine in the treatment of severe depression
โ Scribed by Allison S. Kienke; Jerrold F. Rosenbaum
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 101 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1091-4269
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Venlafaxine is the ยฎrst available antidepressant of the structurally novel SNRI (serotonin noradrenaline-reuptake inhibitor) class of drugs. It resembles the tricyclics in its ability to inhibit presynaptic reuptake of both serotonin and noradrenaline to a clinically signiยฎcant degree. However, it d
The selective serotonin reuptake inhibitors (SSRIs) are recognized as effective as and better tolerated than older antidepressant therapies and have become the drugs of choice in the treatment of mild to moderate depression. However, there is a clinical impression that the SSRIs are less effective t
Modern community-based studies have revealed high prevalence rates for major depression in adults. Despite this high prevalence, many depressed individuals do not seek treatment and only a minority of those that do are prescribed antidepressants. This paper considers the role of antidepressants, esp